See Full Report below….

 

About Broad Street Alerts:

 

Big opportunities in Small Cap’s

 

Broad Street Alerts recent profiles and track record, 153% in verifiable potential gains for our

Members in the last 3 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our members gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49%

 

For our members.

 

These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

 

***Get our small cap profiles, special situation and watch alerts in real time.

We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

 Article:

Not surprisingly, the roster of publicly-traded North American companies whose businesses include at least an element related to medical or recreational cannabis has risen dramatically over the past couple of years.

Many of these companies are far too small, and in some cases have business plans that are too indefinite or otherwise hard to hang one’s hat on, to justify investment by most retail investors. As a result, I’d recommend against investing in the industry’s bit players in this “hot” new investment sector. Of course, cannabis isn’t new, but its rapidly-changing legal status and sustainable market growth leave no one in doubt that the industry is “hot” from an investment viewpoint.

At this point, I’d recommend you limit your own investment in the cannabis industry to companies that have confirmable business plans and communicate well with the investment community through regular press releases and informative regulatory filings.

One example of this class of company is Vancouver, Canada-based Aurora Cannabis Inc. (OTC: ACBFF, $0.37, Market Cap: $46 million), which announced on November 30,2015 it had received a license to distribute medical cannabis nationwide with patient deliveries to beginning back in December 2015. The company’s indoor cannabis growing and processing facility in Alberta province is expected by management to produce nearly 200,000 ounces of medical marijuana annually, making the company one of the largest growers in North America. To date, the company has had no revenue, but that will change as soon as patient deliveries commence.

Scottsdale, Arizona-based Praetorian Property (formerly Cannabis-RX) (OTC: CANA, $0.28, Market Cap: $43 million) is in the property business. In 2014 the company, which has a history of changing its core business fairly regularly, decided to offer property development and management services for cannabis companies. To date, it does not appear the company has operated profitably, so there is certainly a risk that what the company is offering is not what its target market is looking for. Nevertheless, the company had plenty of cash on hand at the end of June and their specialization in cannabis-related real estate services might be a profitable niche in the long run. (Note: The company was not able to file its required quarterly filing with the SEC on time for the September quarter. I’d suggest waiting until this report is made public before investing in these shares, if you decide you otherwise like what you see.)

Denver, Colorado-based MassRoots, Inc. (OTC: MSRT, $1.06, Market Cap: $49 million) is clearly a rising star in the world of cannabis companies. The number of registered users of the company’s social network for medical marijuana users reflects strong and sustained growth last year and there is no reason to expect that growth to slow down in 2016. MassRoots still needs to figure out a way to “monetize” that large and growing user base; reported revenue for the nine months ended September 30 were only $64,000. More importantly, the company reported a $4.2 million operating loss for the same period, about half of which was due to payroll costs and other management and large shareholder compensation. It appears the company has been saving cash by paying for services with its own shares, which, one would hope, can be replaced by operating cash flow and more normal/less expensive payment terms in the new year.

At this stage of the industry’s development, the shares of all of the above companies are going to be prone to significant swings. However, all appear to have core businesses that fill a need and can make money for their shareholders in 2016, so they are certainly worth a look as an average investor’s first three investments in shares of companies that will benefit from the expansion of the cannabis industry in North America. If for any reason any of these companies don’t meet your criteria as a buy right now, don’t despair. I expect 2016 will continue to be a banner year for both new company introductions and increasing financial success for well-managed existing companies.

Source: The Marijuana Times

Broad Street Alerts has not been compensated for the mention of _

(MSRT) (CANA) (ACBFF) and we do not hold any positions.

See Full Report below….

 

About Broad Street Alerts:

 

Big opportunities in Small Cap’s

 

Broad Street Alerts recent profiles and track record, 153% in verifiable potential gains for our

Members in the last 3 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our members gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49%

 

For our members.

 

These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

 

***Get our small cap profiles, special situation and watch alerts in real time.

We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

 

 

 Article:

SASKATOON, SASKATCHEWAN — (Marketwired) — 04/08/16 — Claude Resources Inc. (TSX: CRJ) (OTCQB: CLGRF) (“Claude” and or the “Company”) today announces the SEDAR filing and mailing of the shareholder meeting materials for the previously announced Plan of Arrangement (the “Arrangement”) with Silver Standard Resources Inc. (“Silver Standard”).

The Arrangement

As Claude announced by press release on March 7, 2016, this is a negotiated transaction recommended by Claude’s Board whereby Silver Standard will acquire each outstanding Claude common share (“Common Share”) for 0.185 of a Silver Standard common share and $0.001 in cash (together the “Consideration”), valuing each Common Share at approximately $1.65 based on the closing price of Silver Standard’s common shares at March 4, 2016.

The Meeting

Claude shareholders as of the record date of March 28, 2016 have the right to vote by proxy or in person at the Special Meeting of Claude shareholders (the “Meeting”) to be held on May 18, 2016 at 11:00 a.m. (Saskatoon time) at the Saskatoon Club, Upper Lounge, 417 – 21st Street East, Saskatoon, SK.

Benefits of the Arrangement

 

–  Significant Premium to Claude Shareholders. The Consideration represents a premium of 30% to the closing price of the Claude Shares on the TSX on the last trading day prior to the announcement of the

Arrangement and 25% to the 20-day VWAP of the Silver Standard Shares and the Claude Shares on the TSX.

 

–  Diversification of Single Asset Risks. Single asset and single metal companies are subject to considerably higher specific risks than companies with several projects. Exposure to Silver Standard’s asset portfolio and strong balance sheet will considerably reduce tho risks.

 

–  Participation in the Combined Entity. Claude shareholders will own approximately 31% and maintain significant exposure to the combine company. Claude shareholders will benefit, among other things, from

increased technical expertise, greater ability to finance, asset diversification, greater analyst coverage and increased share liquidity. The combined company is also expected to realize other synergies from the combination of Silver Standard and Claude.

 

–  Continued Participation by Claude Shareholders in the Seabee Gold Operation. The Claude securityholders, through their ownership of Silver Standard Shares, will continue to participate in the value associated with the Seabee Gold Operation. In addition, the combined company will be in a strong position to undertake further exploration and development of the 23,300 hectare land package at Seabee, which remains largely underexplored.

 

–  Fairness Opinions. The Fairness Opinions from National Bank Financial Inc. and Canaccord Genuity Corp. concluded that, subject to and based on the considerations, assumptions and limitations described in the Meeting materials, the Consideration to be received by Claude shareholders pursuant to the Arrangement is fair, from a financial point of view, to Claude shareholders.

 

The Meeting materials will include a Management Proxy Circular that contains, among other things, details concerning the Arrangement, the reasons for and benefits of the Arrangement, the risks associated with the Arrangement, the requirements for the Arrangement to become effective, the procedure for receiving payment for Common Shares, voting at the Meeting and other related matters. Shareholders are urged to carefully review the Management Proxy Circular and accompanying materials as they contain important information regarding the Arrangement and its consequences to shareholders. Assuming a successful shareholder vote and satisfaction of the other conditions required under the Arrangement, including approval of the Arrangement by Silver Standard’s shareholders, closing is expected to occur on or about May 31, 2016.

The Board of Claude Resources Inc. UNANIMOUSLY recommends that shareholders vote IN FAVOUR of the Arrangement.

Your vote is important regardless of how many Common Shares you own. The Company encourages shareholders to read the Meeting materials in detail.

Claude has engaged Laurel Hill Advisory Group (“Laurel Hill”) as its proxy solicitor in connection with the Arrangement and asks that you contact Laurel Hill if you have any questions or require assistance with voting. Laurel Hill can be reached by email at assistance@laurelhill.com or by telephone at 1-877-452-7184 (416-304-0211 collect).

Source: Virtual Strategy Magazine

Broad Street Alerts has not been compensated for the mention of _  

(TSX: CRJ) (OTCQB: CLGRF) and we do not hold any positions.

See Full Report below….

 

About Broad Street Alerts:

 

Big opportunities in Small Cap’s

 

Broad Street Alerts recent profiles and track record, 153% in verifiable potential gains for our

Members in the last 3 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our members gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49%

 

For our members.

 

These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

 

***Get our small cap profiles, special situation and watch alerts in real time.

We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

 Article:

The stock of AEROGROW INTERNATIONAL INCORPORATED (OTCMKTS:AERO) registered an increase of 140% in short interest. AERO’s total short interest was 1,200 shares in April as published by FINRA. Its up 140% from 500 shares, reported previously. With 6,000 shares average volume, it will take short sellers 0 days to cover their AERO’s short positions. The stock increased 9.77% or $0.17 on April 8, hitting $1.91. AeroGrow International, Inc. (OTCMKTS:AERO) has risen 36.43% since September 2, 2015 and is uptrending. It has outperformed by 31.36% the S&P500.

AeroGrow International, Inc. is a developer, marketer, direct-seller and wholesaler of indoor garden systems designed for consumer use in the gardening, cooking, healthy eating, and home and office decor markets. The company has a market cap of $15.72 million. The Firm offers multiple lines of indoor gardens, grow lights, nutrient formula, over 40 seed pod kits, and various cooking, gardening and decor accessories, in the United States and Canada, as well as selected countries in Europe, Asia and Australia. It currently has negative earnings. The Company’s products include indoor gardens and seed pod kits that allow clients to grow: vegetables, such as tomatoes, chili peppers and salad greens; herbs, including cilantro, chives, basil, dill, oregano and mint, and flowers, such as petunias, snapdragons, geraniums and vinca.

Source: Riverside Gazette

Broad Street Alerts has not been compensated for the mention of _  

(NYSE:AERO) and we do not hold any positions.

PDUFA goal date extended by three months to June 28, 2016

BOULDER, Colo.–(BUSINESS WIRE)–Dec. 15, 2015– Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for Clovis’ New Drug Application (NDA) for rociletinib by the standard extension period of three months with the new goal date of June 28, 2016. Rociletinib is an investigational therapy for the treatment of patients with mutant epidermal growth factor receptor (EGFR) non-small cell lung cancer (NSCLC) who have been previously treated with an EGFR-targeted therapy and have the EGFR T790M mutation.

Clovis submitted a Major Amendment on November 16, 2015 in response to the FDA’s request for additional clinical data for both the 500mg and 625mg BID dose patient groups for rociletinib. As expected, the FDA extended the PDUFA goal date to allow additional time for review of the new information requested by the Agency.

About Rociletinib

Rociletinib is the company’s novel, oral, targeted covalent (irreversible) mutant-selective inhibitor of EGFR in development for the treatment of NSCLC in patients with initial activating EGFR mutations, as well as the dominant resistance mutation T790M. Data from both the pivotal, single-arm TIGER-X and TIGER-2 clinical trials served as the basis for the U.S. and EU regulatory submissions for the treatment of advanced mutant EGFR T790M-positive lung cancer. Rociletinib was granted Breakthrough Therapy designation by the FDA in May 2014.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado.

To the extent that statements contained in this press release are not descriptions of historical facts regarding Clovis Oncology, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve substantial risks and uncertainties that could cause our clinical development programs, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties inherent in our clinical development programs for our drug candidates, the corresponding development pathways of our companion diagnostics, actions by the FDA, the EMA or other regulatory authorities regarding whether to approve drug applications that may be filed, as well as their decisions regarding drug labeling, and other matters that could affect the availability or commercial potential of our drug candidates or companion diagnostics, including competitive developments. Clovis Oncology does not undertake to update or revise any forward-looking statements. A further description of risks and uncertainties can be found in Clovis Oncology’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and its reports on Form 10-Q and Form 8-K.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151215006801/en/

Source: Clovis Oncology, Inc.

Clovis Oncology, Inc.
Anna Sussman, 303-625-5022
asussman@clovisoncology.com
or
Breanna Burkart, 303-625-5023
bburkart@clovisoncology.com

See Full Report below….

 

About Broad Street Alerts:

 

Big opportunities in Small Cap’s

 

Broad Street Alerts recent profiles and track record, 153% in verifiable potential gains for our

Members in the last 3 small cap alerts alone!

February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our members gains- 83%

March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.

March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49%

 

For our members.

 

These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.

We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.

 

***Get our small cap profiles, special situation and watch alerts in real time.

We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.

 Article:

The stock of Grana Y Montero Saa (NYSE:GRAM) registered a decrease of 4.5% in short interest. GRAM’s total short interest was 780,900 shares in April as published by FINRA. Its down 4.5% from 817,700 shares, reported previously. With 109,300 shares average volume, it will take short sellers 7 days to cover their GRAM’s short positions. The short interest to Grana Y Montero Saa’s float is 0.87%. The stock decreased 4.37% or $0.18 on April 7, hitting $3.94. About 46,236 shares traded hands. Grana y Montero SAA (ADR) (NYSE:GRAM) has declined 5.05% since August 31, 2015 and is downtrending. It has underperformed by 9.84% the S&P500.

Grana y Montero SAA is a Peru-based holding firm primarily engaged in the four business areas: Construction and Engineering Industry, Real Estate, Oil Services, and Operation of Public Concessions and Business Support Services. The company has a market cap of $499.78 million. Through its subsidiaries, the Company provides such services as the development and management of real estate properties and leisure facilities; the exploration, production and sale of oil, natural gas and its derivates; the storage and distribution of combustibles; information technology services; engineering consultancy; the operation and maintenance of rails and roads concessions; as well as the execution and management of projects related to the generation of electric power; among others. It has 18.31 P/E ratio.

Grana y Montero SAA – Receive News & Ratings Via Email – Enter your e

Source: Riverside Gazette

Broad Street Alerts has not been compensated for the mention of _

(NYSE:GRAM) and we do not hold any positions.